Related Experiment Video
Updated: Aug 28, 2025
08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
8.7K
DNA Methylation Profiling in Rare Sellar Tumors
Kyla Wright1, Kristyn Galbraith2, Matija Snuderl2
1NYU Grossman School of Medicine, New York, NY 10012, USA.
Biomedicines
|September 23, 2022
Summary
DNA methylation profiling accurately diagnosed a rare sellar esthesioneuroblastoma that mimicked a pituitary adenoma. This advanced technique aids in diagnosing challenging central nervous system (CNS) tumors, improving accuracy and patient outcomes.
Area of Science:
- Neuro-oncology
- Genomics
- Pathology
Background:
- Histologic diagnosis of sellar masses, especially rare neoplasms, presents challenges due to inter-observer variability and lack of definitive biomarkers.
- Central nervous system (CNS) tumors can be misclassified, impacting patient prognosis and treatment.
- DNA methylation profiling is emerging as a powerful diagnostic tool for CNS tumors.
